Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges - podcast episode cover

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges

Nov 20, 202454 minEp. 101
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s largest health care companies. They discuss Roche’s leadership in cancer treatment, breakthroughs in diagnostics, and the impact of cutting-edge R&D in areas like precision medicine and AI. Schinecker also shares his views on the rapid growth of China’s pharma industry and the challenges Europe faces in keeping up with global clinical trials.


The production team for this episode includes Isabelle Karlsson and PLAN-B's Niklas Figenschau Johansen, Sebastian Langvik-Hansen and Pål Huuse. Background research was conducted by Sara Arnesen.



Hosted on Acast. See acast.com/privacy for more information.

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges | In Good Company with Nicolai Tangen podcast - Listen or read transcript on Metacast